Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Nektar Therapeutics (NKTR)

2014-11-20@09:00:00 ET
Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a PARP Inhibitor in BRCA1-deficient Cancer Model (PRN)

2014-11-20@08:27:51 ET
Shares of Repros Therapeutics Underperformed its Peers in the Pharmaceuticals Industry (RPRX, SCMP, NKTR, MDCO, SLXP) (F70)

2014-11-19@05:19:17 ET
Global Cervical Cancer Therapeutic Pipeline Review, H2 2014 - 35 Companies & 71 Drug Profiles (MTO)

2014-11-18@14:21:38 ET
Nektar Therapeutics Shares Climbing Higher, Up 2.1% (F77)

2014-11-18@05:58:20 ET
Form 144: Filing to Sell 9900 Shares of Nektar Therapeutics (NKTR) (VKR)

2014-11-17@16:30:57 ET
Nektar Therapeutics Earnings In Retrospect: Up 0.5% in the Last 11 Days (NKTR) (PSM)

2014-11-15@16:12:48 ET
Post Earnings Update: Nektar Therapeutics Has Climbed 0.5% Higher in Past Week (NKTR) (F73)

2014-11-14@12:47:20 ET
Nektar Therapeutics Bearish Moving Average Crossover Alert (NKTR) (F78)

2014-11-13@09:34:10 ET
Nektar Therapeutics reports net income for Q3 (DTM)

2014-11-11@08:24:52 ET
XenoPort has the Best Relative Performance in the Pharmaceuticals Industry (XNPT, NKTR, LLY, SLXP, JAZZ) (F70)

2014-11-11@08:14:46 ET
Possible Bullish Inside Day Candle Pattern Detected for Nektar Therapeutics (NASDAQ:NKTR) (F70)

2014-11-10@12:59:33 ET
Buyers Accumulate Shares of Nektar Therapeutics, Up 1.9% (F77)